Rilpivirine Pharmacokinetics Without and With Darunavir/ritonavir once daily in Adolescents and Young Adults

BACKGROUND: Rilpivirine (RPV), a recently developed, once daily HIV non-nucleoside reverse transcriptase inhibitor (NNRTI), is not currently approved for pediatric patients, but is sometimes prescribed for adolescents with multiple treatment failures, for regimen simplification or to minimize toxici...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pediatr Infect Dis J
Egile Nagusiak: Foca, Marc, Yogev, Ram, Wiznia, Andrew, Hazra, Rohan, Jean-Philippe, Patrick, Graham, Bobbie, Britto, Paula, Carey, Vincent J., King, Jennifer, Acosta, Edward P., Cressey, Tim R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5245132/
https://ncbi.nlm.nih.gov/pubmed/27187753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0000000000001214
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak